By Kim Witczak at brownstone dot org
When my husband Woody died by suicide in 2003, nothing made sense.
Everyone around me said the same thing: "He must have been depressed."
But I lived with him. I knew him. And in the deepest part of me, that explanation didn't fit.
Woody was outgoing, high-functioning, driven, and fully engaged in life. He was training for a marathon, logging his miles, showing up for work, and showing up for us. He wasn't withdrawn or struggling in the ways people typically associate with depression.
The only thing that had changed was that, five weeks earlier, his doctor prescribed him Zoloft - an antidepressant - for insomnia due to his new dream job with a start-up company.
That was it.
We didn't know much about antidepressants then. But after Woody died, we started digging. And what we found was shocking. One discovery led to another. We began connecting the dots. Ultimately, it led us to file a wrongful death/failure to warn lawsuit against Pfizer.
What we uncovered during that legal process changed everything.
Internal documents. Emails. Memos. Strategy decks. Marketing plans. Risk assessments. Quiet acknowledgments of harm.
All buried inside the system.
All on company and FDA letterhead.
All never meant for public eyes.
That's when I learned one of the most sobering truths of my life:
Truth often doesn't come from the doctor's office or the stories we're told. It lives in the documents - in black and white, behind closed doors.
Documents don't lie - they expose.
Once you've looked behind the curtain, you see it clearly: the system runs on spin, shields power, and protects profit - not people.
The BIO Leaked Memo: "It's Time for RFK Jr. to Go."
So when I read this article by James Lyons-Weiler for Brownstone Institute - a think tank I've come to respect for its commitment to questioning powerful systems and fostering honest dialogue - about the leaked BIO memo, where a pharmaceutical lobbying group discussed quietly removing RFK, Jr. and shaping public sentiment, I didn't need convincing.
I've seen this before.
The names change.
But the machinery doesn't.
The leaked internal document - reportedly from Biotechnology Innovation Organization (BIO), the powerful lobbying arm of the pharmaceutical industry - had just come to light. And when I read the April 3, 2025 steering committee document, it was déjà vu all over again.
Because it said the quiet part out loud:
"It is time to go to The Hill and lobby that it is time for RFK Jr. to go…"
Not because of policy disagreements. But because he posed a threat - to the business model. To public scrutiny. To transparency.
The memo outlined a strategic roadmap, naming "influential voices," outlining investor fears, identifying messaging tactics, and spotlighting political allies like former FDA commissioner (now Pfizer board member) Scott Gottlieb and CMS Administrator Dr. Oz. As someone with a career in advertising and marketing, I recognized the blueprint instantly.
On one level, BIO was simply doing its job as a trade group protecting their clients' interests. But on another, it reveals how calculated and controlled the public narrative can be, especially when profits and control are at stake.
This wasn't about protecting science or public health.
This was about managing perception, neutralizing dissent, and maintaining their political capital.
This post isn't about defending RFK, Jr. or debating the politics of the FDA or NIH. It's not about red or blue. It's about something deeper - and far more dangerous: how far industry will go to protect its pockets and control the narrative, no matter who's in charge.
If you've followed my work, you know I've always said healthcare isn't a partisan issue.
It's purple - for people. For the unsuspecting public, like we were almost 22 years ago.
The Campaign Wasn't Public Health. It Was Public Relations.
And the BIO memo isn't the only example of this. There's another document, obtained through a Freedom of Information ...